Close this search box.

We are creating some awesome events for you. Kindly bear with us.

Real-Time Bioinformatics Prediction Platform from CUHK

Image Credits: CUHK, Press Release

The rapid evaluation of COVID-19 vaccine effectiveness (VE) is an urgent need in order to inform and update vaccine design as new genetic variants of the virus continue to emerge. A research team led by Professor Maggie Haitian WANG and Professor Benny Chung Ying ZEE, both from the Jockey Club School of Public Health and Primary Care at the Chinese University of Hong Kong’s (CUHK) Faculty of Medicine (CU Medicine), has developed a computational approach that can rapidly predict the protective effects of COVID-19 vaccines by analysing genetic distance (GD). The research findings have been published in the renowned journal Nature Medicine.

Genetic distance on the receptor-binding domain of spike protein is highly predictive of vaccine protection 

Based on roughly two million SARS-CoV-2 sequences and 49 clinical trials and observational studies, researchers from The Jockey Club School of Public Health and Primary Care at CU Medicine recently developed new algorithms that can be used to rapidly evaluate the VE of different types of vaccines against symptomatic COVID-19 infection.

They discovered that the genetic distance between the receptor-binding domain of the spike protein of the circulating viruses and the vaccine strain is highly predictive of vaccine protection. Their research demonstrated 95% VE prediction accuracy using genome analysis, validated on an independent dataset.

Traditionally, VE can only be achieved after people have been vaccinated and a portion of the population has been infected. After the emergence of new variants, scientists are required to redesign and repeat studies that observe vaccine performance.

The innovative algorithms allow for in silico real-time prediction of vaccine protection against novel variants through virus sequencing data. This approach applies to designing vaccines with optimal estimated effectiveness and improving vaccine clinical trial design and the evaluation of vaccines before they are deployed.

Technology facilitates the selection of candidate vaccine antigens for optimal protection 

Professor Benny Chung Ying ZEE, Director of the Centre for Clinical Research and Biostatistics, from The Jockey Club School of Public Health and Primary Care at CU Medicine stated that the development of in silico algorithms to rapidly evaluate VE is of huge significance to public health, as it can provide a snapshot of vaccine protection before mass vaccination and infection.

He noted that vaccine manufacturers can use this technology to select candidate vaccine antigens and inform clinical trial design. Healthcare workers and policymakers will also be able to estimate the scale of an upcoming epidemic caused by new variants with information about the predicted VE.

Professor Maggie Haitian WANG, Associate Professor also from The Jockey Club School of Public Health and Primary Care at CU Medicine noted that the algorithms presented in the paper can offer timely updates on the expected effectiveness of all types of COVID-19 vaccine.

The VE-GD framework can be used to determine the optimal vaccine compositions that provide the maximum protection against circulating viruses. This can facilitate the design of high-efficacy vaccines against COVID-19, flu and other pathogens.

The global vaccines market is projected to reach US$67.2 billion by 2026, at a CAGR of 10.2%. The global vaccines market (including COVID-19 vaccines) is projected to reach US$149.2 billion by 2026 during the forecast period.

There is increasing government support for and focus on the development of vaccines and immunisation strategies, as well as the growing prevalence of infectious diseases. These factors drive the vaccine market. However, for the development of vaccines the low purchasing power and huge capital may restrain the market growth in developing countries.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


As a Titanium Black Partner of Dell Technologies, CTC Global Singapore boasts unparalleled access to resources.

Established in 1972, we bring 52 years of experience to the table, solidifying our position as a leading IT solutions provider in Singapore. With over 300 qualified IT professionals, we are dedicated to delivering integrated solutions that empower your organization in key areas such as Automation & AI, Cyber Security, App Modernization & Data Analytics, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Renowned for our consulting expertise and delivering expert IT solutions, CTC Global Singapore has become the preferred IT outsourcing partner for businesses across Singapore.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and consulting services provider, helping clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,800 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently, and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity, and service. For more information, visit